CDC reforming COVID-19 guidance … Nearly three-quarters of the U.S. now estimated to be immune to omicron variant … Brain synapse destruction culprit behind Alzheimer’s cognitive decline … Treatment...
In an effort that is hoped to boost memory and reverse cognitive decline, surgeons at Johns Hopkins hospital recently placed a pacemaker-like device into the brain of a patient with Alzheimer’s disease....
Music: The language of well-being
By
Rick Soshensky
Jul 06, 2010
Music can have a profound impact on long-term care residents with cognitive impairment. It triggers memories, improves mood and sparks a feeling of of connection with others.
Report: Hearing loss raises risk for cognitive decline, even without other dementia risks
By
Kristen Fischer
Jan 22, 2024
Hearing loss is a risk factor for cognitive decline that’s independent of other dementia risk factors, according to a new report.
Panel finds no evidence to support effective measures to prevent Alzheimer’s
Apr 30, 2010
An independent panel of medical experts has determined that there is no strong scientific evidence to support several measures for the prevention of cognitive decline and Alzheimer’s disease.
Protein presence in urine predicts risk for cognitive decline
By
Ashley Carman
Sep 03, 2013
The presence of protein in the urine of those with diabetes can signify a risk for cognitive decline, according to a new study.
Lifelong mental stimulation may prevent dementia, despite brain changes
By
Alicia Lasek
Jul 15, 2019
A lifetime of cognitively challenging activity is tied to lower dementia risk, even in people whose brains show signs of Alzheimer’s disease.
Study: ‘Cognitive frailty’ may be result of aging — not the brain changes found in dementia
By
Alicia Lasek
Jan 11, 2022
Reduced cognitive function without substantial memory complaints may be a normal part of aging and not an early sign of Alzheimer’s disease or other dementias, investigators say.
Engage! When social involvement declines, cognitive abilities may follow
By
Alicia Lasek
Jun 28, 2019
Social engagement may be a mark of how resilient – or vulnerable – someone is to cognitive decline, a recent study has found.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.